A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants

Signal Transduct Target Ther. 2022 Jan 11;7(1):10. doi: 10.1038/s41392-021-00821-y.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • COVID-19*
  • Humans
  • SARS-CoV-2*
  • Spike Glycoprotein, Coronavirus

Substances

  • Spike Glycoprotein, Coronavirus
  • Angiotensin-Converting Enzyme 2

Supplementary concepts

  • SARS-CoV-2 variants